NCT00980174 2018-10-17Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With OsteoporosisAmgenPhase 3 Completed242 enrolled 19 charts
NCT00925600 2017-05-30Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone LossAmgenPhase 3 Completed769 enrolled 21 charts